特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
865046

薬物乱用検査の世界市場:2019年~2023年

Drugs of Abuse Testing Market by Product and Geography - Global Forecast and Analysis 2019-2023

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 118 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
薬物乱用検査の世界市場:2019年~2023年
出版日: 2019年06月03日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 118 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

薬物乱用の増加によって、米国FDA、CDC、および麻薬取締機関(DEA)などの様々な政府機関は、薬物使用に関する厳しい規制を課すことを余儀なくされています。これらの規制の実施は、世界の薬物乱用検査市場の成長を牽引しています。例えば、米国の研究者は、研究目的のために大麻を調達するために、米国国立薬物乱用研究所(NIDA)、米国FDA、およびDEAのようなの組織から承認を得る必要があります。さらに、研究者は、研究が行われている場所の様々な州政府部門から追加の承認を得なければなりません。こうした要因によって、2019年から2023年の間に6%近くのCAGRで市場成長が促進される見込みです。

当レポートでは、世界の薬物乱用検査市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年~2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 製品別比較:市場規模および予測(2018年~2023年)
  • 器具
  • 消耗品
  • 市場機会:製品別

第7章 顧客情勢

第8章 地域情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年~2023年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

目次
Product Code: IRTNTR31422

About this market

The growing instances of drug abuse are compelling various governments agencies such as the US FDA, the CDC, and the Drug Enforcement Agency (DEA) impose stringent regulations pertaining to the use of drugs. Implementation of these regulations is driving the growth of the global drugs of abuse testing market. For instance, the researchers in the US are required to get approval from several organizations such as the National Institute on Drug Abuse (NIDA), the US FDA, and the DEA to procure cannabis for their research purposes. Additionally, researchers must secure additional approvals from various state government departments where the research is being conducted. These factors are expected to drive the growth of the market at a CAGR of nearly 6% during 2019-2023.

Market Overview

Increased strategic developments

Vendors in the market are focusing on improving their product offerings and innovations to expand their product portfolios and ensure the availability of drugs of abuse testing to end-users such as research laboratories and academic institutions. Other strategic developments such as new product launches, joint ventures, collaborations, investments, and partnerships, and acquisitions adopted by the vendors are expected to fuel the growth of the global drugs of abuse testing market size during the forecast period.

Manipulation of drug screening tests

There are instances of people evading tests for illicit drugs by manipulating the specimen that was supposed to be subjected to the tests. For example, the easy availability of chemicals such as laundry detergent, table salt, and toilet bowl cleaners give people the liberty to adulterate the specimens to manipulate drug screening tests. This is expected to hinder the growth of the global drugs of abuse testing market size.

For the detailed list of factors that will drive and challenge the growth of the drugs of abuse testing market size during 2019-2023.

Competitive Landscape

The market appears to be fairly concentrated with few players occupying the market share. Companies such as Abbott and Bio-Rad Laboratories Inc. have intensified competition. Factors such as stringent regulatory control on the procurement of cannabis and increased strategic developments will provide significant growth opportunities for drugs of abuse testing companies. Abbott, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc. are some of the major companies covered in this report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Instruments - Market size and forecast 2018-2023
  • Consumables - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Instruments - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Instruments - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Consumables - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Consumables - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by product
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share by geography 2018-2023 (%)
  • Exhibit 26: Geographic comparison
  • Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Key leading countries
  • Exhibit 36: Market opportunity
  • Exhibit 37: Impact of drivers and challenges
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: Abbott - Vendor overview
  • Exhibit 44: Abbott - Business segments
  • Exhibit 45: Abbott - Organizational developments
  • Exhibit 46: Abbott - Geographic focus
  • Exhibit 47: Abbott - Segment focus
  • Exhibit 48: Abbott - Key offerings
  • Exhibit 49: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 50: Bio-Rad Laboratories Inc. - Product segments
  • Exhibit 51: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 52: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 53: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 54: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 55: Danaher Corp. - Vendor overview
  • Exhibit 56: Danaher Corp. - Business segments
  • Exhibit 57: Danaher Corp. - Organizational developments
  • Exhibit 58: Danaher Corp. - Geographic focus
  • Exhibit 59: Danaher Corp. - Segment focus
  • Exhibit 60: Danaher Corp. - Key offerings
  • Exhibit 61: F. Hoffmann-La Roche Ltd - Vendor overview
  • Exhibit 62: F. Hoffmann-La Roche Ltd - Product segments
  • Exhibit 63: F. Hoffmann-La Roche Ltd - Organizational developments
  • Exhibit 64: F. Hoffmann-La Roche Ltd - Geographic focus
  • Exhibit 65: F. Hoffmann-La Roche Ltd - Segment focus
  • Exhibit 66: F. Hoffmann-La Roche Ltd - Key offerings
  • Exhibit 67: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 68: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 69: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 70: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 71: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 72: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 73: Validation techniques employed for market sizing
  • Exhibit 74: Definition of market positioning of vendors
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.